Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence Antonio InserraAlexandre PiotGabriella Gobbi Leading Article 21 August 2023 Pages: 733 - 754
New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System Emilio PeruccaMeir BialerH. Steve White Review Article Open access 21 August 2023 Pages: 755 - 779
New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: II. Treatments in Clinical Development Emilio PeruccaH. Steve WhiteMeir Bialer Review Article Open access 21 August 2023 Pages: 781 - 795
Over the Counter Supplements for Memory: A Review of Available Evidence Haley HersantSean HeGeorge Grossberg Review Article 21 August 2023 Pages: 797 - 817
Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records Vicente VillanuevaCédric LaloyauxBernhard J. Steinhoff Original Research Article Open access 09 September 2023 Pages: 819 - 835
Network Meta-analysis of Different Treatments for Vestibular Migraine Jiann-Jy ChenBing-Syuan ZengPing-Tao Tseng Original Research Article Open access 07 September 2023 Pages: 837 - 847